The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer

• Øystein Helland ,

  * E-mail: Oystein.Helland@uib.no

  Affiliations Department of Obstetrics and Gynecology, Haukeland University Hospital, Jonas Liesvei 72, 5058 Bergen, Norway, Department of Clinical Science, University of Bergen, PB 7804, 5020 Bergen, Norway

  ⨯
• Mihaela Popa,

  Affiliation KinN Therapeutics, Laboratoriebygget, Haukeland University Hospital, 5021 Bergen, Norway

  ⨯
• Katharina Bischof,

  Affiliations Department of Obstetrics and Gynecology, Haukeland University Hospital, Jonas Liesvei 72, 5058 Bergen, Norway, Department of Clinical Science, University of Bergen, PB 7804, 5020 Bergen, Norway

  ⨯
• Bjørn Tore Gjertsen,

  Affiliations Department of Clinical Science, University of Bergen, PB 7804, 5020 Bergen, Norway, Department of Internal Medicine, Haukeland University Hospital, Jonas Lies vei 65, 5021 Bergen, Norway, Centre for Cancer Biomarkers (CCBIO), University of Bergen, 5020 Bergen, Norway

  ⨯
• Emmet McCormack,

  Affiliations Department of Clinical Science, University of Bergen, PB 7804, 5020 Bergen, Norway, Department of Internal Medicine, Haukeland University Hospital, Jonas Lies vei 65, 5021 Bergen, Norway

  ⨯
• Line Bjørge

  Affiliations Department of Obstetrics and Gynecology, Haukeland University Hospital, Jonas Liesvei 72, 5058 Bergen, Norway, Department of Clinical Science, University of Bergen, PB 7804, 5020 Bergen, Norway, Centre for Cancer Biomarkers (CCBIO), University of Bergen, 5020 Bergen, Norway

  ⨯